Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1340 |
|---|---|
| Identifier | NCT05178017 |
| Trial Title | Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS - Irritable Bowel Syndrome |
| Interventions | DIAGNOSTIC_TEST: Leukocyte Activation Assay (LAA-MRT) / Lifestyle Eating and Performance (LEAP) program |
Participant Information
| Sponsor | Oxford Biomedical Technologies, Inc. |
|---|---|
| City | Riviera Beach |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2021-09-01 |
|---|---|
| Primary Completion Date | 2026-12-31 |
| Completion Date | 2026-12-31 |